Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
828 people get BRLI articles and Market Currents by email alert.
Get email alerts on BRLI »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
Earnings Analysis: Quest Diagnostics Inc.CapitalCube • Thu, Oct 18, 2012 -
QE3 And The Buy-Low Sell-High PortfolioMartin Lowy • Mon, Oct 8, 2012
-
Update: 8 High-Growth Healthcare Stocks With Strong Sources Of ProfitabilityKapitall • Tue, Jul 17, 2012
-
9 Highly Shorted, Undervalued Stocks With Positive Receivable TrendsKapitall • Sun, Jun 3, 2012
-
9 Undervalued Small-Cap Stocks Hoarding Cash For The Right OpportunitiesZetaKap • Fri, May 25, 2012 -
-
-
16 Rallying Healthcare Stocks Being Sold By Hedge FundsKapitall • Tue, Feb 21, 2012
-
-
Bio-Reference Laboratories, Inc. Q4FY08 Earnings Call TranscriptThu, Dec 18, 2008
-
Bio-Reference Laboratories, Inc Q3 2008 Earnings Call TranscriptWed, Sep 10, 2008
-
PR Newswire (Thu, 12:14PM)
-
UPDATE -- BioReference Laboratories, Inc. Reports Record Quarterly Results Based on Sustained GrowthGlobeNewswire (Jun 6, 2013)
-
GlobeNewswire (Jun 6, 2013)
-
GlobeNewswire (Jun 5, 2013)
-
GlobeNewswire (May 30, 2013)
-
GlobeNewswire (May 15, 2013)
-
GlobeNewswire (May 8, 2013)
-
GlobeNewswire (Feb 28, 2013)
-
GlobeNewswire (Feb 27, 2013)
-
PR Newswire (Dec 18, 2012)
-
at CNBC.com (Nov 1, 2012)
-
PR Newswire (Oct 10, 2012)
-
at Fox Business (Aug 30, 2012)
-
at Fox Business (Aug 30, 2012)
-
at MarketWatch.com (Aug 30, 2012)
-
at Fox Business (Aug 16, 2012)
BRLI vs. ETF Alternatives
Company Description
We believe that we are the largest independent regional clinical laboratory servicing the greater New York metropolitan area. We offer a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, June 6, 8:35 AM Bio-Reference Labs (BRLI): FQ2 EPS of $0.41 in-line. Revenue of $176.4M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, June 6, 12:05 AM Notable earnings before Thursday’s open: ANN, BRLI, CIEN, FGP, SJM, TITN Comment! [Earnings]
- Wednesday, June 5, 5:30 PM Notable earnings before Thursday’s open: ANN, BRLI, CIEN, FGP, SJM, TITN 1 Comment [Earnings]
- Thursday, February 28, 12:33 PM Bio-Reference Laboratories (BRLI +5.8%) shrugs off a negative article in The Street Sweeper yesterday to trade higher in spite posting a mixed FQ1 earnings report. The company beat on a per share basis but missed on its top line consensus as revenue was impacted from hurrican Sandy. Going forward the company reaffirms its guidance for FY13, still expecting net revenues to increase more than 15% and net income to increase by approximately 20%. Comment! [Healthcare, Earnings, On the Move]
- Thursday, February 28, 12:05 AM Notable earnings before Thursday’s open: AIXG, AWR, BDBD, BKS, BRLI, BRY, CHS, CTRX, CVC, DANG, DPZ, GMXR, GTLS, HK, IRDM, IRM, ISIS, KSS, LKQ, MCGC, MTG, NIHD, OCN, PKT, RDC, RNO, SDRL, SHLD, TD, TTI, VRX, WNR, WPX, WWE Comment! [Earnings]
- Wednesday, February 27, 5:30 PM Notable earnings before Thursday’s open: AIXG, AWR, BDBD, BKS, BRLI, BRY, CHS, CTRX, CVC, DANG, DPZ, GMXR, GTLS, HK, IRDM, IRM, ISIS, KSS, LKQ, MCGC, MTG, NIHD, OCN, PKT, RDC, RNO, SDRL, SHLD, TD, TTI, VRX, WNR, WPX, WWE Comment! [Earnings]
- Thursday, December 6, 2012, 3:35 PM Bio-Reference Laboratories (BRLI +5%) moves up after reporting a largely in-line FQ4, but a 16% Y/Y jump in total revenue. Net profit also rose 23%, as the company again recorded strong revenue growth, despite the impact of Hurricane Sandy on the Northeast regional provider of diagnostic testing for physicians. Revenue per patient rose 4% in the latest quarter, while the number of patients served rose 12%. 1 Comment [Healthcare, Earnings, On the Move]
- Thursday, December 6, 2012, 8:38 AM Bio-Reference Laboratories (BRLI): FQ4 EPS of $0.46 in-line. Revenue of $176.1M (+16% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
- Thursday, August 30, 2012, 2:40 PM Shares of Bio-Reference Laboratories (BRLI -9.5%) get hammered, despite its FQ3 beating on its bottom line earlier today. Net earnings rose 25% Y/Y, as the clinical-testing company's streak of double-digit revenue growth continued, but investors appear to be taking advantage of near 52-week highs to lock in profits as sales growth shows signs of stagnating. 1 Comment [Healthcare, Earnings, On the Move]
- Thursday, August 30, 2012, 8:45 AM Bio-Reference Laboratories (BRLI): Q2 EPS of $0.45 beats by $0.03. Revenue of $172.3M (+16.4% Y/Y) in-line. Shares +4.4% premarket. (PR) 1 Comment [Earnings, Healthcare, On the Move]
- Thursday, August 30, 2012, 12:05 AM Notable earnings before Thursday’s open: BRLI, CIEN, TD Comment! [Earnings]
- Wednesday, August 29, 2012, 5:30 PM Notable earnings before Thursday’s open: BRLI, CIEN, TD 1 Comment [Earnings]
- Thursday, June 7, 2012, 8:42 AM Bio-Reference Laboratories (BRLI): FQ2 EPS of $0.33 beats by $0.01. Revenue of $163.4M (+18.7% Y/Y) beats by $3M. (PR) Comment! [Earnings, Healthcare]
- Thursday, March 1, 2012, 11:25 AM Bio-Reference Laboratories (BRLI +9.1%) pops after beating FQ1 estimates earlier. Revenue jumped 23% Y/Y on double digit sales growth as the clinical-testing company's patient count has risen and its share of complex, non-routine testing services continues to grow. Comment! [Healthcare, Earnings, On the Move]
- Thursday, March 1, 2012, 8:48 AM Bio-Reference Laboratories (BRLI): FQ1 EPS of $0.26 beats by $0.05. Revenue of $150M (+23% Y/Y) beats by $7M. (PR) Comment! [Earnings, Healthcare]
-
- View all 11 replies
-
techwonk: ...but the environment is very tightly controlled. It's not "free enterprise" as we understand it. For Jim Rogers (who lives in China)... -
techwonk: ...and can monitor the situation (he speaks Chinese) it might be a screaming good buy. For you? Maybe if you could follow his trades.
-
- View all 0 replies
-
- View all 0 replies
-
- View all 15 replies
-
SKS1586: andyk80: Mr Market is listening to you & following your thought of bounce, with uptick in all the Futures @ this moment.
-
-
- View all 0 replies
-
- View all 0 replies
-
Michael Bryant
From long-term chart, Bio-Reference Laboratories (BRLI) seem to have consistently yielded 20-50% annually. http://yhoo.it/SMTHcn;c= - View all 0 replies
-
- View all 0 replies
-
freefdawatchlist
http://bit.ly/UcV2Mp Trading ideas for Aug 30th: $CIEN, $TIVO, $OVTI, $BRLI. $VXX $UVXY $TZA, $FAZ - View all 0 replies
-
freefdawatchlist
http://bit.ly/UcV2Mp Premarket watch: All three heavily shorted stock $OVTI, $BRLI, $CIEN, ready to jump 20% on surprise beat. - View all 0 replies
LATEST REPLIES
-
- View all 11 replies
-
techwonk: ...but the environment is very tightly controlled. It's not "free enterprise" as we understand it. For Jim Rogers (who lives in China)...
-
techwonk: ...and can monitor the situation (he speaks Chinese) it might be a screaming good buy. For you? Maybe if you could follow his trades.
-
- View all 15 replies
-
SKS1586: andyk80: Mr Market is listening to you & following your thought of bounce, with uptick in all the Futures @ this moment.
-
-
- View all 1 replies
-
